Marc Yoskowitz

Marc Yoskowitz

Director/Board Member at MEREO BIOPHARMA GROUP PLC

Net worth: - $ as of 31/05/2026

51 year
Health Technology
Consumer Services
Commercial Services

Profile

Marc J.
Yoskowitz
is Chief Executive Officer at Evozyne Inc since 2023.
Mr. Yoskowitz is Independent Director at Mereo BioPharma Group Plc since 2022.
Former roles include Independent Non-Executive Director at Endo LP from 2024 to 2025, Senior VP-Strategy & Corporate Development at Hospira, Inc., Associate Principal at McKinsey & Co., Inc., Chief Business Officer at Pfizer Essential Health, Chief Strategy Officer & Executive Vice President at Tempus, Inc., and Chief Strategy Officer & EVP-Life Sciences at Tempus AI, Inc. from 2019 to 2024.
Education includes undergraduate studies at Washington University in St. Louis and graduate studies at Columbia Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/03/2026 0 ( -.--% ) - $ 31/05/2026

Marc Yoskowitz active positions

CompaniesPositionStart
MEREO BIOPHARMA GROUP PLC Director/Board Member 10/11/2022
Chief Executive Officer 04/01/2023

Former positions of Marc Yoskowitz

CompaniesPositionEnd
ENDO, INC. Director/Board Member 30/07/2025
Corporate Officer/Principal 01/01/2024
TEMPUS AI, INC. Corporate Officer/Principal 01/01/2024
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Marc Yoskowitz's experience

Training of Marc Yoskowitz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Health Technology

Commercial Services

Consumer Non-Durables

Health Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Marc Yoskowitz
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!